A chimeric gene was constructed by fusing the DNA sequences containing the 5 1 flanking region of the mouse al(III) collagen gene to the coding sequence of the bacterial chloramphenicol acetyltransferase (CAT) gene. Transient transfection experiments indicated that the al(III) promoter is active in NIH 3T3 fibroblasts and BC 3 H1 smooth muscle cells.
INTRODUCTION
Collagens are a family of structural proteins that form the biological scaffolding of many tissues (1). Since the collagen phenotype determines to a great extent the overall tissue structure, precise modulation of collagen synthesis is crucial to the function of tissues, as well as the organism as a whole. While type I collagen is the most abundant protein in higher organisms, type III collagen is found in the fibrillar network of blood vessels, lung, and skin, complementing type I collagen in these tissues.
Expression of collagen genes is regulated during development (2, 3, 4) , transformation (5, 6, 7) , and by various factors (8, 9) . Type I and type III collagens are regulated in a similar manner by certain agents. Fibroblasts transformed with the oncogene vsrc or v-mos synthesize ten to twenty fold less type I and type III collagen mRNA (6, 7) . The levels of both collagens are affected by TGF-B (8) , as well as hepatic fibrogenic factor (9) . Since both proteins are commonly expressed by the same cells, and are affected by the same agents, it can be postulated that both genes may share common regulatory elements.
Regulatory elements that control both the temporal and tissue specific expression of genes are most often located 5' to the transcriptional start site of the coding sequence (10) . Several type I collagen genes have been isolated and their promoter sequences identified (11, 12, 13, 14) . The mouse a2(I) collagen promoter has been analyzed both by deletion mutations and by small substitution mutations using a CAT recombinent vector and the transcient transfection assay in fibroblasts (15, 16) . The transciptional initiation site of the mouse al(III) gene has previously been identified, and the sequences upstream of this site sequenced (17) . In order to study the function of this upstream region, a 2.3 Kb fragment containing the promoter sequence was placed in front of the "reporter" gene CAT (18) . The activity of the promoter was studied by introducing a recombinent al(III) collagen promoter-CAT gene construction into cultured cells, and measuring the levels of CAT protein synthesized.
MATERIALS AND METHODS
Cell lines: NIH 3T3 and CV1 cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10* calf serum, 2mM glutamine and Penicillin-Streptomycin (50U/ml, 50 ug/ml). BC3HI cells were maintained in DMEM supplemented with 20% fetal calf serum, 2mM glutamine and Penicillin-Streptomycin (50U/ml, 50 ug/ml). BC3HI cell line is derived from smooth muscle cells (19) .
Plasmid constructions. Plasmid pPrC3 was constucted by replacing the a2(I) collagen promoter of pAZ1009 (15) Eco Rl-Acc 1 fragment, from the genomic clone lambda C3 5A had the Eco Rl site converted to an Xho site, and the Ace 1 site converted to a Hind III site (Figure 1 ). In plasmid pHM104 the SV40 enhancer sequences were deleted. All further constructions are based on pMM104. Plasmids pMM102, pMM103, and pMMHO utilized restriction sites Bgl II, Ava I, and Xba I, respectively, to construct the deletion mutations. Plasmid pMM104 was linearized with the appropriate restriction enzyme, the ends were made blunt, and the DNA was ligated. Plasmid pMM114 was constructed by converting the Nde I site at -2 00 to an Xho I site, and ligating the 200 bp Xho I-Hind III fragment into an Xho I-Hind III vector. Plasmid pMM120 was constructed by converting a Fok I site at -80 to and Xho I site and ligating a 96 bp (-80 to +16) fragment into the above vector. Bal 31 nuclease treatment was used to generate small deletions. Plasmid pMM104 was digested with Xba I, treated with Bal 31 nuclease, the staggered ends were converted to blunt ends using the Klenow fragment of DNA polymerase, and Xho I linkers were ligated to these blunt ends. After digest with Xho I and Hind III, fragments ranging in size from 400 to 250 bp were isolate from a polyacrylamide gel, and ligated into a pMMlO4 vector which had been digested with Xho I and Hind III. Deletions were analyzed by sizing the Xho I-Hind III fragments on polyacrylamide gels. Eucarvotic Cell Transfections and CAT Assays. Plasmid DNA was transfected into cultured cells by the method of Gorman et al (18) . Cells were plated at a density of 2xlO 5 /l°° i™ dish for NIH 3T3 and BC 3 H1 cells, and 10 6 /l°° ™n di -sh for CV1 cells. Cells were transfected with 10-15 ug of CsCl purified plasmid DNA using the CaPO 4 coprecipitation technique. Four hours after the addition of DNA the cells were submitted to a 15% glycerol shock for 2 min., and then placed in media containing serum. Cells were harvested 4 0 hrs. after the addition of the DNA, and the extracts were assayed for JCAT activity according to the method of Gorman et al (18) . The modification of the Gorman protocol involved addition of acetyl CoA to 2.5 mM, and extending the B pPrC3 pMM104 duration of the incubation to 8 -14 hrs. The data was quantitated by scintillation counting of the acetylated products. Primer Extension Analysis. Messenger RNA transcription initiation site analysis was performed with RNA isolated from NIH 3T3 fibroblasts 4 0 hrs. after transfection of plasmid pMM114. Total RNA was prepared by the guanidiniun/CsCl procedure described in Maniatis et al (20) . A 24-mer oligonucleotide complementary to the CAT mRNA was end labelled using mercaptoethanol, 2.5 mM each dNTP, and 10 units of reverse transcriptase. The reaction was incubated for 1 hr. at 37°. After phenol extraction, ethanol precipitation, and a 30 min. incubation in 0.1 N NaOH at 37°, the sample was adjusted to 5 M urea and 0.01* bromphenol blue, and boiled for 2 min. The extension products were analyzed on an 8% sequencing gel. RESULTS Activity of the mouse alflll) collagen promoter. The isolation and identification of the mouse al(III) collagen promoter has been previously reported (16) . A unique transcriptional start site was contained within a 2. constructions were active in NIH 3T3 fibroblasts, but that pPrC3 had approximately a ten fold higher activity than pMM104 ( Figure  1 ). The activity of the mouse al(III) collagen promoter is approximately five to ten fold lower than the activity of an analogous mouse a2(I) collagen promoter (data not shown). These levels of activity reflect the relative ratio of type III to type I collagen synthesized by cultured fibroblasts. Deletion Analysis. The initial deletion study of the al(Ill) collagen promoter involved removing large regions of the promoter. This first series of mutations removed progressively more 5 1 sequence, leaving the cap-proximal (Figure 3 ). There were no larger transcripts, and no extended products were found in the control reaction. This result indicated that the increase in acivity was not due to transcription originating in the adjacent vector sequences, since transcription initiated from the start site of the al(III) collagen promoter.
The greatest increase in activity occured when sequences from -400 to -200 were deleted. To further define which sequence within this 200 bp region was responsible for this effect, Bal 31 nuclease deletions between -400 and -200 were generated and analyzed. As in the previous constructions, the 3 1 end of the promoter remained unchanged, only 5 1 end sequences were deleted.
Plasmids pHM2 04 and pMM205 which had deleted sequences to -365 and -350, respectively, had the same activity as pMMHO, a mutation with a deletion endpoint at -400. Plasmids pMM209 and pHM207 which had sequences deleted to -300 and -285, respectively, had the same activity as pMM114, or eight fold more activity then the parent plasmid ( figure 4) . These deletions were also tested in CVl and BH3CI cells where they had the same relative activity as in the NIH 3T3 cells (data not shown). The progressively larger deletions did not exhibit a gradual increase in activity, but rather there was an increase when a 50 bp sequence was deleted.
The deletion mutation pMM120, which contained 80 bp of promoter sequence had a relatively high level of activity -2.5 fold higher then the 200 bp promoter plasmid pMM114. The activity of this deletion plasmid was compared to a mouse collagen a2(I) deletion construction. Both constructions have 
DISCUSSION
The current study examines the elements regulating the mouse al(III) collagen promoter. Initial analysis indicated that this promoter is relatively weak, having 10 to 20 percent of the activity of the mouse a2(I) collagen promoter. Subsequent deletion analysis suggested that the al(III) promoter, unlike the a2(I) collagen, is regulated predominately by negative regulatory elements. Further deletion studies identified a 50 bp sequences that inhibited the expression of the promoter. Truncating the al(III) promoter further to -80 resulted in a still higher level of expression. This finding indicated that the first 80 bp of the al(III) promoter are sufficient for a relatively high level of expression. In contrast, truncating the a2(I) promoter to 100 bp resulted in decreased expression, due to removal of positive regulatory elements located further upstream. Thus dissimilar promoters govern the expression of these two collagen genes that are often coordinately regulated in various tissues.
Two types of plasmid constructions containing the mouse al(III) collagen 5' flanking sequences were used in the initial experiments. Including the SV40 enhancer sequences in the al(III) CAT plasmid construction stimulated the activity of the al(III) promoter, similar to the affect previously seen by the addition of the SV4 0 enhancer sequences to an a2(I) promoter (15) , as well as other promoters (23, 24, 25) . However, since enhancer elements may interfere with normal regulation, in the current study, all the deletion analysis of the al(III) promoter were conducted with plasmid constructions that did not contain enhancer sequences.
The first series of deletions involved the removal of 5' sequences, and progressively reducing the size of the promoter. These experiments demonstrated that removal of sequences upstream of -400 did not affect the expression of the CAT gene. Further deletion to -200 increased the activity of the promoter 8 fold. Primer extension analyses of the 200 bp promoter plasmid indicated that mRNA transcription originated from within the al(III) promoter sequence, providing further evidence that the increase in activity was dependent on the removal sequences that inhibited promoter activity.
The sequences responsible for this increase in activity were localized by Bal 31 deletion analysis. Incremental deletions indicated that sequences located between -350 and -300 were inhibiting the expression of the promoter. Inspection of this 50 bp sequence revealed that this region contains imperfect direct repeat sequences, separated by ten bp. This arrangement would place the two direct repeat sequences on the saae face of the DNA helix. If this region contains a protein binding site, correct sequence alignment may by important for the protein interactions. Alternatively direct repeat sequences would allow the formation of slip structures which have been implicated in gene regulation (26) . This 50 bp region contains a sequences that has partial homology with the a2(I) collagen promoter. In preliminary DNA footprint experiments, the direct repeat sequences are protected, providing evidence that this 50 bp region is involved in protein interactions (unpublished results A. Hamatochi).
Our results indicated that the 120 bp sequence located between -200 and -80 exerts a small negative affect on the expression of the al(III) collagen promoter. In contrast, a deletion of a2(I) promoter sequences to -104 produces a plasmid that has less then one tenth of the activity of the parent 2 kb a2(I) promoter construction. Thus deletion of upstream sequences from the a2(I) promoter removes positive regulatory elements essential for optimal activity, while deletion of comparable sequences of the al(III) promoter removes negative elements.
Comparison of the first 8 0 and 104 bp of the two collagen promoters reveals that they share few elements (figure 6). The only region that is highly conserved surrounds the TATA box sequence. The a2(I) promoter has a CCAAT box sequence located at -80 (on the template strand), which binds a heterodimer that has been purified to homogeneity (20) . Binding of this protein to the -80 region of the a2(I) promoter is not competed by an -80 bp region of the al(III) promoter (21) . The segment containing this sequence in the a2(I) promoter is the binding site for a transacting factor, which stimulates the a2(I) collagen promoter in a cell-free system (S. Meity, P. Golumbek, G. Karsenty and B. de Crombrugghe, unpublished results). Furthermore, point mutations in the CCAAT motif which inhibit binding of the factor, also show a decreased promoter activity in DNA transfection experiments (16) .
The absence of this sequence in the al(III) promoter may be critical in differential regulation of these collagen genes.
The al(III) promoter does have two sequences that may be important for the expression. A nuclear factor 1 binding site consensus sequence is located around -4 0 (figure 7), and a SV4 0 enhancer core consensus sequence is found around -52. These sequences are not present in the first 104 bp of the a2(I) promoter, and may be responsible for the high level of activity of the al(III) truncated promoter.
Results of the deletion analysis of the a2(I) (15) and al(III) collagen promoter suggest that the two promoters are regulated by different mechanisms. These observations must take into account that the studies were conducted primarily with cultured fibroblasts. Other tissues which express collagens at higher levels may utilize sequences that could not be analyzed in this study. However, results obtained with cultured smooth muscle cells were identical to those found with cultured fibroblasts.
Finally, regulation of transcription is only one mechanism that regulates the expression of genes. Previous reports presented evidence that both the al(III) and the a2(I) collagen genes may subject to translation control (27) . This mode of regulation could account for one level of coordinate gene control. It is also possible that other regulatory elements are located either further upstream or perhaps downstream of the sequences analyzed in this study. This study demonstrates that promoters of two genes that are often coordinately expressed are regulated in a different manner, indicating that various regulatory mechanisms can be employed to modulate gene expression.
